Our ultimate goal over the coming years is to accelerate brain function in individuals affected by DDX3X through advances in gene therapy and pharmaceuticals.

Join us for our next Family Day!

Research History

In late 2014 the first patient with a DDX3X gene mutation was identified and by yearend eight girls had been diagnosed. In the following months, researchers from around the world collaborated to investigate DDX3X gene mutations. The culmination of their work led to the August 6, 2015 paper published in The American Journal of Genetics. This first DDX3X report created a correlation, a community, and this organization.

Since 2015 the DDX3X Foundation has been connecting families, resources, and the medical community to advance research for a cure to DDX3X gene mutations. Annually, the Foundation hosts a weekend conference for families and researchers. Researchers represented have included:

  • Karlla Brigatti, MS, Genetic Counselor, Clinic for Special Children
  • Randy J. Chandler, PhD, Staff Scientist, National Human Genome Research Institute at the National Institutes of Health (NIH)
  • Maria Escolar, MD, Director of the Program for the Study of Neurodevelopment in Rare Disorders, Children’s Hospital of Pittsburgh of UPMC
  • Kevin Francis, PhD, Assistant Professor, Department of Pediatrics at the Sanford School of Medicine at the University of South Dakota
  • Robert Jinks, PhD, Professor of Neuroscience, Biological Foundations of Behavior program at Franklin & Marshall College
  • Bethany Johnson-Kerner, MD, Ph.D, Research Fellow, Univerity of California, San Francisco (UCSF)
  • Jane Juusola, PhD, Director of the Whole Sequencing Program, GeneDX
  • Kevin Strauss, MD, Medical Director, Clinic for Special Children
  • Linda Richards, PhD, Professor of Neuroscience and Deputy Director, Queensland Brain Institute at The University of Queensland (Australia)
  • Elliott Sherr, MD, PhD, Professor in Neurology and Pediatrics, Institute of Human Genetics and the Weill Institute of Neurosciences at the University of California, San Francisco (UCSF)
  • Debra L. Silver, PhD, Associate Professor, Departments of Molecular Genetics and Microbiology, Cell Biology, and Neurobiology and Director of Graduate Studies at Duke Developmental and Stem Cell Biology

Determined to advance research, the DDX3X Foundation began the process to become a 501(c)(3) nonprofit to find a cure. A partnership with Delaware Community Foundation was formed to raise money in the interim. The Foundation has contributed more than $120,000 for DDX3X research at Dr. Sherr’s lab at UCSF and sixty DDX3X families have enrolled in his lab’s brain development research program.

In 2018, two DDX3X papers have been published: A March 18, 2018 paper builds upon the previously published paper and the May 11, 2018 paper, featuring 78 individuals, is the largest clinical cohort to date.

Momentum to unlock the potential of individuals with DDX3X gene mutations continues to build as the rosters of researchers and diagnosed families grows each day.




As a pediatric neurologist, Elliott Sherr, MD, PhD has spent a significant portion of his career studying the brains of children with malformations. When a beautiful young girl presented in his clinic with dysgenesis of the corpus callosum, he went above and beyond to help her family find answers—which ended up being a mutation of her DDX3X gene. Three years later he is going above and beyond for all children with DDX3X mutations. Individuals with DDX3X are included in his lab’s Brain Development Research Program which seeks to better understand the function of the DDX3X gene.



Board certified in neurodevelopmental disabilities, Maria Luisa Escolar, MD, MS established the Program for the Study of Neurodevelopment in Rare Disorders (NDRD) to help children and their families understand the impact of rare neurological diseases on child development. In late 2017, Dr. Escolar began seeing individuals with DDX3X gene mutations in her clinic. Rare diseases, especially newly discovered disorders like DDX3X gene mutations, are poorly understood. As more and more patients participant in Dr. Escolar’s natural history study—consisting of several evaluations, an MRI, and an exam—their journey adds to a collective body of knowledge to help families meet the challenges of day-to-day life with DDX3X and science advance research on rare condition.



The study of skin biopsy samples from individuals with DDX3X gene mutations could allow researchers to improve the function of the mutated DDX3X gene. Parents interested in providing a skin sample of their child, as well as their own, to be stored at the Coriell Institute should contact Tara Schmidlen ([email protected] or 856-757-4822). Tara is the genetic counselor and coordinator who works closely with a host of patient registries and individual families and can help work out the logistics of providing a sample. Be sure to specify that your child has a DDX3X gene mutation. The Coriell Institute is a large public biobank with a long and successful experience banking patient samples for a host of different genetic disorders. Stored samples will allow researchers from around the world to access them for free if they’re contributing to the bank (or the researcher who has contributed gives them access).



Brain Development Study

Complete the intake form and family history form. Contact Lindsey Suit ([email protected]) with questions.


Natural History Study

Contact program coordinator Brie Yanniello ([email protected] or 412-692-6350) to schedule an appointment.


Skin Sample Study

Contact Tara Schmidlen ([email protected] or 856-757-4822) to provide a skin sample of your child, as well as your own, to be stored at the Coriell Institute.


Patient Registry

There is power in numbers. Join our patient registry to add your child to the growing number of children with DDX3X.

How to get in touch

If you have any questions about any of these research opportunities, or want to simply get in touch to learn more, please don’t hesitate to contact us.

Contact Us